HuGE Literature Finder
|
||
Records 1-26
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
Contribution of rare germline copy number variations and common susceptibility loci in Lynch Syndrome patients negative for mutations in the mismatch repair genes.
International journal of cancer. Journal international du cancer 2015 Dec . Villacis Rolando A R, Miranda Priscila M, Gomy Israel, Santos Erika M M, Carraro Dirce M, Achatz Maria I, Rossi Benedito M, Rogatto Silvia |
|
Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
Gut 2014 Feb 63 (2): 326-36. Ma Xiangyu, Zhang Ben, Zheng W |
|
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
DNA and cell biology 2013 Jun 32 (6): 329-35. Han Fei-fei, Guo Chang-long, Liu Li-ho |
|
CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Arquivos de gastroenterologia 2012 Dec 49 (4): 273-8. Abud Jamile, Prolla João Carlos, |
|
CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Cancer epidemiology 2012 Oct 36 (5): 453-7. Bayram Süleyman, Topakta? Mehmet, Akk?z Hikmet, Bekar Aynur, Akgöllü Ers |
|
Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer.
Mutagenesis 2012 Mar 27 (2): 219-23. Tomlinson Ian P M, Houlston Richard S, Montgomery Grant W, Sieber Oliver M, Dunlop Malcolm |
|
The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2051-5. Liu Chuan, Wang Qing-Shui, Wang Ya-J |
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
The pharmacogenomics journal 2011 Dec 11 (6): 437-43. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez |
|
Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.
European journal of cancer (Oxford, England : 1990) 2011 Nov 47 (17): 2546-51. Xiang He-ping, Geng Xiao-ping, Ge Wei-wei, Li |
|
DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
Carcinogenesis 2011 Jun 32 (6): 882-7. Gao Ying, Hayes Richard B, Huang Wen-Yi, Caporaso Neil E, Burdette Laurie, Yeager Meredith, Chanock Stephen J, Berndt Sonja |
|
CHEK2 mutations and HNPCC-related colorectal cancer.
International journal of cancer. Journal international du cancer 2010 Jun 126 (12): 3005-9. Suchy Janina, Cybulski Cezary, Woko?orczyk Dominika, Oszurek Oleg, Górski Bohdan, Debniak Tadeusz, Jakubowska Anna, Gronwald Jacek, Huzarski Tomasz, Byrski Tomasz, Dziuba Ireneusz, Gogacz Marek, Wi?niowski Rafa?, Wandzel Piotr, Banaszkiewicz Zbigniew, Kurzawski Grzegorz, K?adny Józef, Narod Steven A, Lubi?ski J |
|
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
British journal of cancer 2009 Jul 101 (2): 357-62. Kweekel D M, Antonini N F, Nortier J W R, Punt C J A, Gelderblom H, Guchelaar H |
|
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.
British journal of cancer 2009 May 100 (9): 1508-12. Gronwald J, Cybulski C, Piesiak W, Suchy J, Huzarski T, Byrski T, Gorski B, Debniak T, Szwiec M, Wokolowczyk D, Matuszewski M, Sun P, Lubinski J, Narod S |
|
The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
European journal of cancer (Oxford, England : 1990) 2009 Mar 45 (4): 618-24. Kleibl Zdenek, Havranek Ondrej, Hlavata Ivona, Novotny Jan, Sevcik Jan, Pohlreich Petr, Soucek Pav |
|
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Aug 14 (15): 4989-94. Wasielewski Marijke, Vasen Hans, Wijnen Juul, Hooning Maartje, Dooijes Dennis, Tops Carli, Klijn Jan G M, Meijers-Heijboer Hanne, Schutte Mie |
|
Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Mar 16 (3): 572-6. Cybulski Cezary, Gliniewicz Bart?omiej, Sikorski Andrzej, K?adny Józef, Huzarski Tomasz, Gronwald Jacek, Byrski Tomasz, Debniak Tadeusz, Gorski Bohdan, Jakubowska Anna, Wokolorczyk Dominika, Narod Steven A, Lubiñski J |
|
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
European journal of human genetics : EJHG 2007 Feb 15 (2): 237-41. Cybulski Cezary, Woko?orczyk Dominika, K?adny Józef, Kurzawski Grzegorz, Kurzwaski Grzegorz, Suchy Joanna, Grabowska Ewa, Gronwald Jacek, Huzarski Tomasz, Byrski Tomasz, Górski Bohdan, D Ecedil Bniak Tadeusz, Narod Steven A, Lubi?ski J |
|
Increased risk of breast cancer associated with CHEK2*1100delC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Jan 25 (1): 57-63. Weischer Maren, Bojesen Stig Egil, Tybjaerg-Hansen Anne, Axelsson Christen Kirk, Nordestgaard Børge Grøn |
|
CHEK2 I157T associates with familial and sporadic colorectal cancer.
Journal of medical genetics 2006 Jul 43 (7): e34. Kilpivaara O, Alhopuro P, Vahteristo P, Aaltonen L A, Nevanlinna |
|
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.
BMC cancer 2006 6 (): 64. Isinger Anna, Bhat Misha, Borg Ake, Nilbert M |
|
Colorectal cancer and the CHEK2 1100delC mutation.
Genes, chromosomes & cancer 2005 Aug 43 (4): 377-82. de Jong Mirjam M, Nolte Ilja M, Te Meerman Gerard J, van der Graaf Winette T A, Mulder Marcel J, van der Steege Gerrit, Bruinenberg Marcel, Schaapveld Michael, Niessen Renée C, Berends Maran J W, Sijmons Rolf H, Hofstra Robert M W, de Vries Elisabeth G E, Kleibeuker Jan |
|
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
The Journal of pathology 2005 Jun 206 (2): 198-204. van Puijenbroek Marjo, van Asperen Christi J, van Mil Anneke, Devilee Peter, van Wezel Tom, Morreau Ha |
|
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma.
Cancer letters 2003 Oct 200 (2): 149-52. Lipton Lara, Fleischmann Christina, Sieber Oliver M, Thomas Huw J W, Hodgson Shirley V, Tomlinson Ian P M, Houlston Richard |
|
CHEK2 I157T and colorectal cancer in Bulgaria.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 15 (2): 314-7. Konstantinova D, Kadiyska T, Sokolova V, Kaneva R, Mirchev M, Savov A, Aleksandrova A, Nedin D, Kostadinov E, Damyanov D, Kremensky I, Mitev |
|
The CHEK2 1100delC variant in Swedish colorectal cancer.
Anticancer research 0 26 (6C): 4885-8. Djureinovic Tatjana, Lindblom Annika, Dalén Johan, Dedorson Stefan, Edler David, Hjern Fredrik, Holm Jörn, Lenander Claes, Lindforss Ulrik, Lundqvist Nils, Olivecrona Hans, Olsson Louise, Påhlman Lars, Rutegård Jörgen, Smedh Kennet, Törnqvist Anders, Eiberg Hans, Bisgaard Marie Lui |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: